 Comparison acetorphan clonidine opiate withdrawal symptoms OBJECTIVE METHOD authors effects acetorphan enkephalinase inhibitor clonidine treatment opioid withdrawal syndrome Nineteen patients synthetic opiates undergoing drug withdrawal withdrawal syndrome DSM-III criteria days hospital setting double-blind trial subjects clonidine objective signs subjective symptoms withdrawal RESULTS several objective signs effect acetorphan marked clonidine drugs similar efficacy respect subjective components withdrawal side effect subjects CONCLUSIONS Enkephalinase inhibition novel safe therapeutic approach opioid withdrawal syndrome